We welcome media interested in obtaining information and reporting on cancer issues. Registration for ESMO Asia 2017 is free to bona fide journalists on presentation of a letter of assignment and a valid press card.
Media representatives are required to observe and abide by the ESMO Media Policy.
Media registration
To register for ESMO Asia 2017, please complete the media registration form. Media registration in advance is strongly recommended although on-site registration will be possible.
Complete the Media Registration Form
Please contact the ESMO Press Office for any additional inquiry.
ESMO Asia 2017 Programme and Abstracts
For details about the Official ESMO Asia 2017 Programme and Abstracts, please click here.
ESMO Asia 2017 press programme
All abstracts selected for the ESMO Asia 2017 Congress press programme, will be accompanied by a press release distributed accordingly with the following Embargo lift:
ID |
Abstract title |
Authors |
Abstract Embargo SGT |
410O_PR |
Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study |
Tony S.K. Mok et al. |
Sat. 18 Nov. 00:05 hrs (SGT) |
288O_PR |
Determinants of cancer screening awareness and participation among Indonesian women: A nationwide study |
Sumadi Lukman Anwar et al. |
Sat. 18 Nov. 00:05 hrs (SGT) |
35P_PR |
Analysis of EGFR mutation status in blood and CSF in lung adenocarcinoma patients with EGFR mutation and CNS metastasis by ddPCR |
Yang Sen et al. |
Sat. 18 Nov. 00:05 hrs (SGT) |
372P_PR |
Head and neck cancer occurrences and Lifestyle habits in Toungoo, Myanmar |
Khin Khin Nwe et al. |
Sat. 18 Nov. 00:05 hrs (SGT) |
LBA4_PR |
Mainstreaming Genetic Counselling for Genetic Testing of BRCA1 and BRCA2 in Ovarian Cancer Patients in Malaysia (MaGiC Study) |
Sook Yee Yoon et al. |
Sat. 18 Nov. 00:05 hrs (SGT) |
91O_PR |
Analysis of the gaps on metastatic breast cancer policies and advocacy efforts to support policy development across the patient journey in Asia |
Katherine Hunt et al. |
Sun. 19 Nov. 00:05 hrs (SGT) |
LBA3_PR |
Randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer (mCRC), comparing the efficacy and safety of XELIRI + bevacizumab versus FOLFIRI + bevacizumab (AXEPT) |
Tae Won Kim et al. |
Sun. 19 Nov. 00:05 hrs (SGT) |
LBA6_PR |
Osimertinib vs standard of care (SoC) EGFR-TKI as first-line treatment in patients with EGFR-TKI sensitising mutation (EGFRm) positive advanced non-small cell lung cancer (NSCLC): FLAURA Asian subset |
Tae Won Kim et al. |
Sun. 19 Nov. 00:05 hrs (SGT) |
Publication schedule for accepted abstracts
- Abstracts accepted for presentation at ESMO Asia 2017 as Mini Oral and Poster will be published online on the ESMO website at 07:05 SGT (local Singapore Time) on Wednesday, 8 November 2017.
- Abstracts accepted for presentation at ESMO Asia 2017 as Proffered Paper (oral presentation) will be published online on the ESMO website at 07:05 SGT (local Singapore Time) on Wednesday, 15 November 2017.
- Late-breaking abstracts will be made public at the beginning of the official ESMO Asia 2017 Congress session during which they are presented.
- Abstracts, including LBAs, selected for the official ESMO Press Programme will be made public at 00:05 hrs SGT (local Singapore Time) on the day of presentation in the official ESMO Asia 2017 Congress programme.
Abstract accepted as: |
Publication time |
|---|---|
|
Wednesday, 08 November 2017 |
|
Wednesday, 15 November 2017 |
|
Beginning of the official ESMO Asia 2017 Congress session during which they are presented |
|
(additional suffix ‘_PR’) |
Third Party Media Activities
For details concerning media activities in connection with ESMO Asia 2017 Congress, please check the ESMO Policy on Activites organized by Third Parties
Contact
ESMO Press Office
E-mail: media@esmo.org